Antiverse raises $9.3M Series A to scale AI-driven antibody discovery from Cardiff

The Next Web
Read full post
Antiverse secured $9.3 million in Series A funding to advance its AI-driven platform for discovering antibodies, aiming to accelerate drug development from its base in Cardiff.

More in Healthcare

Google DeepMind Releases AlphaGenome Atlas Mapping 9 Billion Human DNA

Forbes
Healthcare3 min read

Mark Wahlberg is coming to TechCrunch Disrupt 2026, and he wants to talk about your work, not his

TechCrunch

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources